Jimmie Zhang
About Jimmie Zhang
Jimmie Zhang is a Clinical Trial Manager at Akero Therapeutics, where he has worked since 2021. He has extensive experience in the biopharmaceutical industry, focusing on therapeutic cures for virologic diseases and oncology.
Work at Akero Therapeutics
Jimmie Zhang has been serving as a Clinical Trial Manager at Akero Therapeutics since 2021. In this role, he oversees the planning, execution, and management of clinical trials. His responsibilities include coordinating with cross-functional teams to ensure compliance with regulatory requirements and timelines. Akero Therapeutics focuses on developing innovative therapies for liver diseases, and Zhang's expertise contributes to advancing the company's clinical objectives.
Previous Experience at Gilead Sciences
Prior to his current position, Jimmie Zhang worked at Gilead Sciences for two years as a Clinical Trial Management Associate from 2019 to 2021. He also held the role of Clinical Project Associate II for nine months in 2018. During his time at Gilead, Zhang gained extensive experience in managing clinical trials and supporting project teams in the biopharmaceutical sector, particularly in virology and oncology.
Background in Clinical Trials
Jimmie Zhang began his career in clinical trials as a Clinical Trial Associate at Santen in 2018. His experience also includes a role as a Regulatory Affairs Intern at Gilead Sciences in 2017 and a Systems Engineering Intern at Five Prime Therapeutics in 2016. These positions provided him with a solid foundation in clinical operations and regulatory processes within the biopharmaceutical industry.
Education and Expertise
Jimmie Zhang graduated from the University of California, Berkeley, where he earned a Bachelor of Arts in Molecular Biology, specializing in Immunology, from 2014 to 2018. His academic background equips him with a strong understanding of biological sciences, which he applies in his work in clinical trials focused on therapeutic cures and drugs for virologic diseases and oncology.